UPDATE : Saturday, February 22, 2020
Bridge Biotherapeutics, Konkuk University to develop back-eye diseases treatment by Lee Han-soo 2020-02-12 14:49
GC’s sales rose but profits fell in 2019 by Lee Han-soo 2020-02-12 11:40
Medipost’s sales edge up, losses widen last year by Lee Han-soo 2020-02-12 11:40
MSD Korea workers unhappy with spinoff plan by Kim Yun-mi 2020-02-11 14:57
Fake news about new coronavirus drug candidate goes viral by Kim Yun-mi 2020-02-11 12:33
Novartis' new drug for mutated lung cancer gets insurance coverage by Kim Yun-mi 2020-02-10 18:29
Hanmi Pharmaceutical renews yearly profit records by Shim Hyun-tai 2020-02-10 12:29
Court acquits Nature Cell president of stock manipulation by Jeong Sae-im 2020-02-07 18:40
Handok’s medicine for childhood hypophosphatasia gets insurance benefits by Kim Eun-young 2020-02-07 15:59
AstraZeneca Korea leaves umbrella trade union by Jeong Sae-im 2020-02-07 14:35
Experts caution against hasty use of Olumiant for new coronavirus by Kim Yun-mi 2020-02-06 16:08
MSD to spin off women’s health, biosimilars under new firm by Kim Yun-mi 2020-02-06 13:07
Helixmith presents study results of neuropathic pain treatment by Shim Hyun-tai 2020-02-05 18:43
‘Baricitinib emerges as potential treatment for new coronavirus’ by Lee Han-soo 2020-02-05 16:32
Medytox, Daewoong in final battle over BTX strain ownership by Jeong Sae-im 2020-02-05 12:41
Interferon, Kaletra to get insurance benefit for new coronavirus treatment by Kim Yun-mi 2020-02-04 16:39
‘Gilead’s drug candidate effective to fight new coronavirus’ by Kim Yun-mi 2020-02-04 16:39
Boryung Holdings sets up US offshoot by Lee Han-soo 2020-02-03 16:28
Drug firms minimize gatherings, hospital visits as coronavirus fear spreads by Jeong Sae-im 2020-02-03 15:21
New coronavirus affect related stocks in different ways by Jeong Sae-im 2020-01-30 17:36
Back to Top